venlafaxine xr

$52M Total Revenue in North America in 2013
$53.4M Total Revenue in North America in 2012
$61.5M Total Revenue in North America in 2011

Insightful reports built by experienced analysts on venlafaxine xr. We bring you 1 report from 2 markets, comparing venlafaxine xr-related activities versus 1 topic, applying 1 measure.
World and United States are considered as the most covered markets. venlafaxine xr is tightly harmonized with following topics: Pfizer.

Explore related

First 6 related reports

explore more